PriceTargets.com logo

Siemens Healthineers - SHL Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: €0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
€42.59 As of 12/3/2025 01:00 AM ET
▼ -0.08 (-0.19%)

This chart shows the closing price for SHL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Siemens Healthineers Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SHL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SHL

Analyst Price Target is €0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Siemens Healthineers in the last 3 months. The average price target is €0.00, with a high forecast of €0.00 and a low forecast of €10,000,000.00. The average price target represents a -100.00% upside from the last price of €42.59.

This chart shows the closing price for SHL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Siemens Healthineers. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/30/2023BarclaysSet Target€63.00
3/29/2023JPMorgan Chase & Co.Set Target€67.20
3/29/2023Deutsche Bank AktiengesellschaftSet Target€64.00
3/29/2023Sanford C. BernsteinSet Target€58.00
3/29/2023Jefferies Financial GroupSet Target€49.00
3/7/2023Sanford C. BernsteinSet Target€58.00
2/6/2023Berenberg BankSet Target€58.00
2/3/2023Deutsche Bank AktiengesellschaftSet Target€64.00
2/2/2023Jefferies Financial GroupSet Target€50.00
2/2/2023JPMorgan Chase & Co.Set Target€62.10
1/27/2023JPMorgan Chase & Co.Set Target€62.10
1/25/2023UBS GroupSet Target€59.00
1/12/2023JPMorgan Chase & Co.Set Target€62.10
1/10/2023BarclaysSet Target€63.00
1/4/2023Deutsche Bank AktiengesellschaftSet Target€64.00
1/2/2023JPMorgan Chase & Co.Set Target€62.10
1/2/2023Jefferies Financial GroupSet Target€50.00
12/26/2022JPMorgan Chase & Co.Set Target€62.10
12/26/2022Jefferies Financial GroupSet Target€50.00
12/20/2022Jefferies Financial GroupSet Target€50.00
12/20/2022JPMorgan Chase & Co.Set Target€62.10
12/2/2022Berenberg BankSet Target€58.00
11/28/2022UBS GroupSet Target€59.00
11/23/2022Jefferies Financial GroupSet Target€50.00
11/22/2022BarclaysSet Target€64.00
11/9/2022UBS GroupSet Target€56.00
11/9/2022BarclaysSet Target€62.00
11/9/2022Jefferies Financial GroupSet Target€53.00
11/9/2022JPMorgan Chase & Co.Set Target€63.10
11/8/2022Berenberg BankSet Target€54.00
10/18/2022Jefferies Financial GroupSet Target€53.00
10/4/2022BarclaysSet Target€62.00
9/30/2022Jefferies Financial GroupSet Target€61.00
9/29/2022JPMorgan Chase & Co.Set Target€63.10
8/31/2022UBS GroupSet Target€56.00
8/25/2022UBS GroupSet Target€56.00
8/19/2022JPMorgan Chase & Co.Set Target€63.10
8/4/2022BarclaysSet Target€64.00
8/3/2022UBS GroupSet Target€59.00
8/3/2022JPMorgan Chase & Co.Set Target€69.40
8/3/2022Jefferies Financial GroupSet Target€75.00
8/3/2022Deutsche Bank AktiengesellschaftSet Target€64.00
7/4/2022BarclaysSet Target€66.00
7/4/2022Deutsche Bank AktiengesellschaftSet Target€64.00
6/30/2022Jefferies Financial GroupSet Target€75.00
6/30/2022Berenberg BankSet Target€75.00
6/29/2022JPMorgan Chase & Co.Set Target€69.40
6/23/2022UBS GroupSet Target€59.00
5/31/2022BarclaysSet Target€67.00
5/25/2022JPMorgan Chase & Co.Set Target€69.40
5/5/2022Deutsche Bank AktiengesellschaftSet Target€71.00
5/5/2022Berenberg BankSet Target€75.00
5/4/2022UBS GroupSet Target€59.00
5/4/2022The Goldman Sachs GroupSet Target€74.00
5/4/2022JPMorgan Chase & Co.Set Target€71.10
4/27/2022JPMorgan Chase & Co.Set Target€71.10
4/20/2022The Goldman Sachs GroupSet Target€74.00
4/14/2022The Goldman Sachs GroupSet Target€74.00
4/4/2022Berenberg BankSet Target€75.00
3/31/2022Deutsche Bank AktiengesellschaftSet Target€71.00
3/30/2022JPMorgan Chase & Co.Set Target€71.10
3/30/2022Jefferies Financial GroupSet Target€75.00
3/30/2022BarclaysSet Target€60.00
3/23/2022The Goldman Sachs GroupSet Target€74.00
2/9/2022Sanford C. BernsteinSet Target€69.00
2/7/2022JPMorgan Chase & Co.Set Target€71.10
2/4/2022BarclaysSet Target€60.00
2/3/2022UBS GroupSet Target€59.00
2/3/2022The Goldman Sachs GroupSet Target€76.00
2/3/2022Jefferies Financial GroupSet Target€75.00
2/3/2022Berenberg BankSet Target€75.00
2/3/2022Sanford C. BernsteinSet Target€72.00
1/31/2022JPMorgan Chase & Co.Set Target€77.50
1/27/2022Berenberg BankSet Target€75.00
1/21/2022The Goldman Sachs GroupSet Target€76.00
1/20/2022Jefferies Financial GroupSet Target€75.00
1/19/2022Credit Suisse GroupSet Target€71.00
1/18/2022JPMorgan Chase & Co.Set Target€77.50
1/13/2022Deutsche Bank AktiengesellschaftSet Target€75.00
1/12/2022JPMorgan Chase & Co.Set Target€77.50
1/11/2022Kepler Capital MarketsSet Target€65.00
1/4/2022JPMorgan Chase & Co.Set Target€77.50
1/4/2022Nord/LBSet Target€60.00
12/29/2021Nord/LBSet Target€60.00
12/23/2021Kepler Capital MarketsSet Target€65.00
12/22/2021Nord/LBSet Target€60.00
12/17/2021Kepler Capital MarketsSet Target€65.00
12/17/2021BarclaysSet Target€60.00
11/25/2021Kepler Capital MarketsSet Target€65.00
11/23/2021Berenberg BankSet Target€75.00
11/23/2021Jefferies Financial GroupSet Target€62.00
11/19/2021Kepler Capital MarketsSet Target€65.00
11/18/2021Credit Suisse GroupSet Target€71.00
11/18/2021Deutsche Bank AktiengesellschaftSet Target€75.00
11/18/2021JPMorgan Chase & Co.Set Target€77.50
11/17/2021Jefferies Financial GroupSet Target€53.00
11/17/2021UBS GroupSet Target€59.00
11/16/2021BarclaysSet Target€54.00
11/9/2021Deutsche Bank AktiengesellschaftSet Target€68.00
11/5/2021UBS GroupSet Target€54.00
11/4/2021Kepler Capital MarketsSet Target€57.50
11/4/2021Jefferies Financial GroupSet Target€53.00
11/1/2021JPMorgan Chase & Co.Set Target€58.70
10/28/2021Kepler Capital MarketsSet Target€57.50
10/13/2021UBS GroupSet Target€54.00
10/5/2021BarclaysSet Target€54.00
10/4/2021Credit Suisse GroupSet Target€60.00
9/27/2021Deutsche Bank AktiengesellschaftSet Target€64.00
9/27/2021BarclaysSet Target€54.00
9/27/2021Jefferies Financial GroupSet Target€53.00
9/24/2021JPMorgan Chase & Co.Set Target€58.70
9/20/2021Jefferies Financial GroupSet Target€53.00
9/14/2021Berenberg BankSet Target€64.00
9/10/2021BarclaysSet Target€55.00
9/8/2021Jefferies Financial GroupSet Target€53.00
9/2/2021Nord/LBSet Target€60.00
8/3/2021Credit Suisse GroupSet Target€60.00
8/2/2021Kepler Capital MarketsSet Target€57.50
8/2/2021JPMorgan Chase & Co.Set Target€58.70
7/30/2021Berenberg BankSet Target€56.00
7/30/2021BarclaysSet Target€49.00
7/27/2021JPMorgan Chase & Co.Set Target€54.40
7/15/2021BarclaysSet Target€49.00
7/14/2021Morgan StanleySet Target€46.40
7/6/2021JPMorgan Chase & Co.Set Target€54.40
6/25/2021DZ BankReiterated RatingNeutral
6/21/2021JPMorgan Chase & Co.Set TargetBuy€54.40
6/17/2021Kepler Capital MarketsSet TargetBuy€54.00
6/15/2021JPMorgan Chase & Co.Set TargetBuy€54.40
6/14/2021UBS GroupSet TargetNeutral€48.00
6/11/2021Credit Suisse GroupSet TargetBuy€55.00
5/10/2021Kepler Capital MarketsSet TargetBuy€54.00
5/5/2021Nord/LBSet TargetBuy€56.00
5/4/2021DZ BankReiterated RatingNeutral
5/4/2021UBS GroupSet TargetNeutral€46.00
5/4/2021Independent ResearchSet TargetNeutral€51.00
5/4/2021Deutsche Bank AktiengesellschaftSet TargetBuy€56.00
5/4/2021Credit Suisse GroupSet TargetBuy€55.00
5/3/2021Kepler Capital MarketsSet TargetBuy€52.00
5/3/2021JPMorgan Chase & Co.Set TargetBuy€55.30
4/30/2021BarclaysSet TargetNeutral€47.00
4/29/2021Berenberg BankSet TargetBuy€56.00
4/27/2021JPMorgan Chase & Co.Set TargetBuy€55.30
4/21/2021JPMorgan Chase & Co.Set TargetBuy€55.30
3/26/2021Independent ResearchSet TargetNeutral€48.00
3/9/2021Kepler Capital MarketsSet TargetBuy€51.00
3/3/2021Kepler Capital MarketsSet TargetBuy€51.00
2/23/2021UBS GroupSet TargetNeutral€46.00
2/8/2021Deutsche Bank AktiengesellschaftSet TargetNeutral€46.00
2/8/2021Berenberg BankSet TargetBuy€55.00
2/8/2021Credit Suisse GroupSet TargetBuy€54.00
2/3/2021DZ BankReiterated RatingNeutral
2/3/2021Sanford C. BernsteinSet TargetBuy€53.00
1/29/2021Independent ResearchSet TargetNeutral€47.00
1/27/2021Sanford C. BernsteinSet TargetBuy€48.00
1/27/2021Kepler Capital MarketsSet TargetBuy€51.00
1/27/2021Berenberg BankSet TargetBuy€54.00
1/27/2021Credit Suisse GroupSet TargetBuy€48.00
1/26/2021Royal Bank Of CanadaSet TargetNeutral€42.00
1/25/2021Morgan StanleySet TargetBuy€46.40
1/20/2021Berenberg BankSet TargetBuy€54.00
1/12/2021BarclaysSet TargetNeutral€41.00
1/8/2021DZ BankReiterated RatingNeutral
1/7/2021Sanford C. BernsteinSet TargetBuy€48.00
12/24/2020Sanford C. BernsteinSet TargetBuy€48.00
12/18/2020Sanford C. BernsteinSet TargetBuy€48.00
12/15/2020Nord/LBSet TargetBuy€52.00
12/10/2020Kepler Capital MarketsSet TargetBuy€46.00
12/9/2020Morgan StanleySet TargetBuy€46.40
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.17 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Siemens Healthineers logo
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Read More

Today's Range

Now: €42.59
Low: €42.21
High: €42.94

50 Day Range

MA: €45.78
Low: €41.29
High: €49.53

52 Week Range

Now: €42.59
Low: €45.51
High: €58.14

Volume

889,179 shs

Average Volume

N/A

Market Capitalization

€48.05 billion

P/E Ratio

24.76

Dividend Yield

1.65%

Beta

0.7

Frequently Asked Questions

What sell-side analysts currently cover shares of Siemens Healthineers?

The following equities research analysts have issued research reports on Siemens Healthineers in the last twelve months:
View the latest analyst ratings for SHL.

What is the current price target for Siemens Healthineers?

0 Wall Street analysts have set twelve-month price targets for Siemens Healthineers in the last year. has the lowest price target set, forecasting a price of €10,000,000.00 for Siemens Healthineers in the next year.
View the latest price targets for SHL.

What is the current consensus analyst rating for Siemens Healthineers?

Siemens Healthineers currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SHL.

What other companies compete with Siemens Healthineers?

Other companies that are similar to Siemens Healthineers include Drägerwerk AG & Co. KGaA, Stratec, Merck KGaA, Bayer Aktiengesellschaft and Sartorius Aktiengesellschaft. Learn More about companies similar to Siemens Healthineers.

How do I contact Siemens Healthineers' investor relations team?

Siemens Healthineers' physical mailing address is Henkestrasse 127, Erlangen 91052, Germany. The company's listed phone number is 49 69 6682 6602. The official website for Siemens Healthineers is www.healthcare.siemens.de. Learn More about contacing Siemens Healthineers investor relations.